| The therapeutic potential of poly (ADP-ribose) polymerase inhibitors L Virag, C Szabó Pharmacological reviews 54 (3), 375-429, 2002 | 1852 | 2002 |
| Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation SC Soriano FG, Virag L, Jagtap P, Szabo E, Mabley JG Nat Med 7, 108-13, 2001 | 806* | 2001 |
| Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention L Virág, É Szabó, P Gergely, C Szabó Toxicology letters 140, 113-124, 2003 | 646 | 2003 |
| Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: IκBα degradation, induction of nitric oxide synthase, induction of … T Eaves-Pyles, K Murthy, L Liaudet, L Virág, G Ross, FG Soriano, ... The Journal of Immunology 166 (2), 1248-1260, 2001 | 396 | 2001 |
| Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock G Haskó, DG Kuhel, ZH Németh, JG Mabley, RF Stachlewitz, L Virág, ... The Journal of Immunology 164 (2), 1013-1019, 2000 | 380 | 2000 |
| Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving … MN Ajuebor, AM Das, L Virág, RJ Flower, C Szabó, M Perretti The Journal of Immunology 162 (3), 1685-1691, 1999 | 371 | 1999 |
| Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction P Pacher, L Liaudet, P Bai, JG Mabley, PM Kaminski, L Virág, A Deb, ... Circulation 107 (6), 896-904, 2003 | 358 | 2003 |
| Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation E Gilad, HR Wong, B Zingarelli, L Virág, M O'connor, AL Salzman, ... The FASEB Journal 12 (9), 685-693, 1998 | 352 | 1998 |
| Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthase C Szabó, L Virág, S Cuzzocrea, GS Scott, P Hake, MP O’Connor, ... Proceedings of the National Academy of Sciences 95 (7), 3867-3872, 1998 | 340 | 1998 |
| Poly (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death L Virág, AL Salzman, C Szabó The Journal of Immunology 161 (7), 3753-3759, 1998 | 325 | 1998 |
| Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos N Robinson, R Ganesan, C Hegedűs, K Kovács, TA Kufer, L Virág Redox biology 26, 101239, 2019 | 302 | 2019 |
| Poly (ADP-ribose) signaling in cell death L Virág, A Robaszkiewicz, JMR Vargas, F Javier Oliver Molecular Aspects of Medicine, 2013 | 292 | 2013 |
| Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase L Liaudet, FG Soriano, É Szabo, L Virág, JG Mabley, AL Salzman, ... Proceedings of the National academy of Sciences 97 (18), 10203-10208, 2000 | 263 | 2000 |
| Peroxynitrite‐induced thymocyte apoptosis: the role of caspases and poly (ADP‐ribose) synthetase (PARS) activation L Virag, GS Scott, S Cuzzocrea, D Marmer, AL Salzman, C Szabo Immunology 94 (3), 345-355, 1998 | 257 | 1998 |
| Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents P Jagtap, FG Soriano, L Virág, L Liaudet, J Mabley, É Szabó, G Haskó, ... Critical care medicine 30 (5), 1071-1082, 2002 | 252 | 2002 |
| Activation of poly (ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation L Liaudet, PÁL Pacher, JG Mabley, L Virág, FG Soriano, G Haskó, ... American journal of respiratory and critical care medicine 165 (3), 372-377, 2002 | 249 | 2002 |
| Activation of poly (ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure P Pacher, L Liaudet, P Bai, L Virag, JG Mabley, G Hasko, C Szabo Journal of Pharmacology and Experimental Therapeutics 300 (3), 862-867, 2002 | 238 | 2002 |
| A2A adenosine receptors and C/EBPβ are crucially required for IL-10 production by macrophages exposed to Escherichia coli B Csóka, ZH Németh, L Virág, P Gergely, SJ Leibovich, P Pacher, CX Sun, ... Blood, the Journal of the American Society of Hematology 110 (7), 2685-2695, 2007 | 231 | 2007 |
| Suppression of macrophage inflammatory protein (MIP)‐1α production and collagen‐induced arthritis by adenosine receptor agonists C Szabó, GS Scott, L Virág, G Egnaczyk, AL Salzman, TP Shanley, ... British journal of pharmacology 125 (2), 379-387, 1998 | 229 | 1998 |
| Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition … C Szabó, JG Mabley, SM Moeller, R Shimanovich, P Pacher, L Virág, ... Molecular Medicine 8, 571-580, 2002 | 228 | 2002 |
Csaba SzaboProfessor, Chair of Pharmacology, University of Fribourg, SwitzerlandVerified email at unifr.ch
